Emu oil expedites small intestinal repair following 5-fluorouracil-induced mucositis in rats

Experimental Biology and Medicine

Volumn 238, Issue 11, 2013, Pages 1305-1317

  Mashtoub, Suzanne ^a,b   Tran, Cuong D ^a,b   Howarth, Gordon S ^a,b  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Chemotherapy; emu oil; intestinal mucositis; rat; repair

Indexed keywords

DIGESTIVE TRACT AGENT; EMU OIL; FLUOROURACIL; MUCIN; MYELOPEROXIDASE; OLIVE OIL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENTERITIS; FEMALE; FOOD INTAKE; GOBLET CELL; HISTOLOGY; ILEUM; INTESTINE CRYPT; INTESTINE VILLUS; JEJUNUM; MUCOSA INFLAMMATION; NONHUMAN; ORGAN WEIGHT; RAT; WEIGHT GAIN; WEIGHT REDUCTION;

CHEMOTHERAPY; EMU OIL; INTESTINAL MUCOSITIS; RAT; REPAIR;

ANIMALS; CYTOKINES; ENERGY METABOLISM; FEMALE; FLUOROURACIL; INTESTINE, SMALL; JEJUNUM; MUCOSITIS; OILS; ORGAN SIZE; RATS; RATS, INBRED STRAINS; TIME FACTORS; WOUND HEALING;

EID: 84887207666     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370213493718     Document Type: Article

References (49)

1. Choi K,Lee SS,Oh SJ,Lim SY,Jeon WK,Oh TY,Kim JW.The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test.Clin Nutr. 2007;26:57-62.
2. Lalla RV,Peterson DE.Treatment of mucositis, including new medications.Cancer J. 2006;12:348-54.
3. Gibson RJ,Keefe DM,Clarke JM,Regester GO,Thompson FM,Goland GJ,Edwards BG,Cummins AG.The effect of keratinocyte growth factor on tumour growth and small intestinal mucositis after chemotherapy in the rat with breast cancer.Cancer Chemother Pharmacol. 2002;50:53-8.
4. Tooley KL,Howarth GS,Butler RN.Mucositis and non-invasive markers of small intestinal function.Cancer Biol Ther. 2009;8:753-8.
5. Gibson RJ,Bowen JM,Keefe DM.Palifermin reduces diarrhea and increases survival following irinotecan treatment in tumor-bearing DA rats.Int J Cancer. 2005;116:464-70.
6. Logan RM,Stringer AM,Bowen JM,Yeoh AS,Gibson RJ,Sonis ST,Keefe DM.The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs.Cancer Treat Rev. 2007;33:448-60.
7. Sonis ST.Pathobiology of mucositis.Semin Oncol Nurs. 2004;20:11-5.
8. Sonis ST,Elting LS,Keefe D,Peterson DE,Schubert M,Hauer-Jensen M,Bekele BN,Raber-Durlacher J,Donnelly JP,Rubenstein EB.Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients.Cancer. 2004;100:1995-2025.
9. Kaczmarek A,Brinkman BM,Heyndrickx L,Vandenabeele P,Krysko DV.Severity of doxorubicin-induced small intestinal mucositis is regulated by the TLR-2 and TLR-9 pathways.J Pathol. 2012;226:598-608.
10. Melo ML,Brito GA,Soares RC,Carvalho SB,Silva JV,Soares PM,Vale ML,Souza MH,Cunha FQ,Ribeiro RA.Role of cytokines (TNF-alpha, IL-1beta and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide.Cancer Chemother Pharmacol. 2008;6:775-84.
11. Cheah KY,Howarth GS,Yazbeck R,Wright TH,Whitford EJ,Payne C,Butler RN,Bastian SEP.Grape seed extract protects IEC-6 cells from chemotherapy-induced cytotoxicity and improves parameters of small intestinal mucositis in rats with experimentally-induced mucositis.Cancer Biol Ther. 2009;8:382-90.
12. Prisciandaro LD,Geier MS,Butler RN,Cummins AG,Howarth GS.Probiotic factors partially improve parameters of 5-fluorouracil-induced intestinal mucositis in rats.Cancer Biol Ther. 2011;11:671-7.
13. Prisciandaro LD,Geier MS,Butler RN,Cummins AG,Howarth GS.Evidence supporting the use of probiotics for the prevention and treatment of chemotherapy-induced intestinal mucositis.Crit Rev Food Sci Nutr. 2011;51:239-47.
14. Wright TH,Yazbeck R,Lymn KA,Whitford EJ,Cheah KY,Butler RN,Feinle-Bisset C,Pilichiewicz AN,Mashtoub S,Howarth GS.The herbal extract, Iberogast, improves jejunal integrity in rats with 5-fluorouracil (5-FU)-induced mucositis.Cancer Biol Ther. 2009;8:923-9.
15. Al-Okbi SY. Nutraceuticals of anti-inflammatory activity as complementary therapy for rheumatoid arthritis. Toxicol Ind Health. Epub ahead of print 26 October 2012. DOI: 10.1177/0748233712462468.
16. Miles EA,Calder PC.Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis.Br J Nutr. 2012;107:S171-84.
17. Torres DM,Tooley KL,Butler RN,Smith CL,Geier MS,Howarth GS.Lyprinol only partially improves indicators of small intestinal integrity in a rat model of 5-fluorouracil-induced mucositis.Cancer Biol Ther. 2008;7:295-302.
18. Tenikoff D,Murphy KJ,Le M,Howe PR,Howarth GS.Lyprinol (stabilised lipid extract of New Zealand green-lipped mussel): a potential preventative treatment modality for inflammatory bowel disease.J Gastroenterol. 2005;40:361-5.
19. Abimosleh SM,Lindsay RJ,Butler RN,Cummins AG,Howarth GS.Emu oil increases colonic crypt depth in a rat model of ulcerative colitis.Dig Dis Sci. 2012;57:887-96.
20. Abimosleh SM,Tran CD,Howarth GS.Emu oil: a novel therapeutic for disorders of the gastrointestinal tract?.J Gastroen Hepatol. 2012;27:857-61.
21. Whitehouse MW,Turner AG,Davis CK,Roberts MS.Emu oil(s): a source of non-toxic transdermal anti-inflammatory agents in aboriginal medicine.Inflammopharmacology. 1998;6:1-8.
22. Snowden JM,Whitehouse MW.Anti-inflammatory activity of emu oils in rats.Inflammopharmacology. 1997;5:127-32.
23. Yoganathan S,Nicolosi R,Wilson T,Handelman G,Scollin P,Tao R,Binford P,Orthoefer F.Antagonism of croton oil inflammation by topical emu oil in CD-1 mice.Lipids. 2003;38:603-7.
24. Lindsay RJ,Geier MS,Yazbeck R,Butler RN,Howarth GS.Orally administered emu oil decreases acute inflammation and alters selected small intestinal parameters in a rat model of mucositis.Br J Nutr. 2010;104:513-9.
25. Tomas FM,Knowles SE,Owens PC,Read LC,Chandler CS,Gargosky SE,Ballard FJ.Effects of full-length and truncated insulin-like growth factor-I on nitrogen balance and muscle protein metabolism in nitrogen-restricted rats.J Endocrinol. 1991;128:97-105.
26. Grem JL.5-Fluorouracil:forty-plus and still ticking. A review of its preclinical and clinical development.Inves New Drugs. 2000;18:299-313.
27. Portolesi R,Powell BC,Gibson RA.Competition between 24:5n-3 and ALA for Delta 6 desaturase may limit the accumulation of DHA in HepG2 cell membranes.J Lipid Res. 2007;48:1592-8.
28. Murthy SN,Cooper HS,Shim H,Shah RS,Ibrahim SA,Sedergran DJ.Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin.Dig Dis Sci. 1993;38:1722-34.
29. Howarth GS,Xian CJ,Read LC.Predisposition to colonic dysplasia is unaffected by continuous administration of insulin-like growth factor-I for twenty weeks in a rat model of chronic inflammatory bowel disease.Growth Fact. 2000;18:119-33.
30. Pelton NC,Tivey DR,Howarth GS,Davidson GP,Butler RN.A novel breath test for the non-invasive assessment of small intestinal mucosal injury following methotrexate administration in the rat.Scand J Gastroenterol. 2004;39:1015-6.
31. Yazbeck R,Howarth GS,Geier MS,Demuth HU,Abbott CA.Inhibiting dipeptidyl peptidase activity partially ameliorates colitis in mice.Front Biosci. 2008;13:6850-8.
32. Howarth GS,Francis GL,Cool JC,Xu X,Byard RW,Read LC.Milk growth factors enriched from cheese whey ameliorate intestinal damage by methotrexate when administered orally to rats.J Nutr. 1996;126:2519-30.
33. Tazuke Y,Maeda K,Wasa M,Satoko N,Fukuzawa M.Protective mechanism of glutamine on the expression of proliferating cell nuclear antigen after cisplatin-induced intestinal mucosal injury.Pediatr Surg Int. 2011;27:151-8.
34. Chang WC,Chapkin RS,Lupton JR.Predictive value of proliferation, differentiation and apoptosis as intermediate markers for colon tumorigenesis.Carcinogenesis. 1997;18:721-30.
35. Hong MY,Lupton JR,Morris JS,Wang N,Carroll RJ,Davidson LA,Elder RH,Chapkin RS.Dietary fish oil reduces O6-methylguanine DNA adduct levels in rat colon in part by increasing apoptosis during tumor initiation.Cancer Epidemiol Biomarkers Prev. 2000;9: 819-26.
36. Smith CL,Geier MS,Yazbeck R,Torres DM,Butler RN,Howarth GS.Lactobacillus fermentum BR11 and fructo-oligosaccharide partially reduce jejunal inflammation in a model of intestinal mucositis in rats.Nutr Cancer. 2008;60:757-67.
37. Cool JC,Dyer JL,Xian CJ,Butler RN,Geier MS,Howarth GS.Pre-treatment with insulin-like growth factor-I partially ameliorates 5-fluorouracil-induced intestinal mucositis in rats.Growth Horm IGF Res. 2005;15:72-82.
38. Stringer AM,Gibson RJ,Logan RM,Bowen JM,Yeoh AS,Hamilton J,Keefe DM.Gastrointestinal microflora and mucins may play a critical role in the development of 5-fluorouracil-induced gastrointestinal mucositis.Exp Biol Med (Maywood). 2009;234: 430-41.
39. Soares PM,Mota JM,Gomes AS,Oliveira RB,Assreuy AM,Brito GA,Santos AA,Ribeiro RA,Souza MH.Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution.Cancer Chemother Pharmacol. 2008;63:91-8.
40. Cheng H,Bjerknes M.Whole population cell kinetics of mouse duodenal, jejunal, ileal, and colonic epithelia as determined by radioautography and flow cytometry.Anat Rec. 1982;203:251-64.
41. Logan RM,Stringer AM,Bowen JM,Gibson RJ,Sonis ST,Keefe DM.Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered?.Cancer Chemother Pharmacol. 2009;63:239-51.
42. Drozdowski L,Thomson AB.Intestinal mucosal adaptation.World J Gastroenterol. 2006;12:4614-27.
43. Haxhija EQ,Yang H,Spencer AU,Sun X,Teitelbaum DH.Intestinal epithelial cell proliferation is dependent on the site of massive small bowel resection.Pediatr Surg Int. 2007;23:379-90.
44. Duncan M,Grant G.Oral and intestinal mucositis - causes and possible treatments.Aliment Pharmacol Ther. 2003;18:853-74.
45. Lopez A,Sims DE,Ablett RF,Skinner RE,Leger LW,Lariviere CM,Jamieson LA,Martinez-Burnes J,Zawadzka GG.Effect of emu oil on auricular inflammation induced with croton oil in mice.Am J Vet Res. 1999;60:1558-61.
46. Qiu XW,Wang JH,Fang XW,Gong ZY,Li ZQ,Yi ZH.Anti-inflammatory activity and healing-promoting effects of topical application of emu oil on wound in scalded rats.Di Yi Jun Yi Da Xue Xue Bao. 2005;25:407-10.
47. Calder PC.n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases.Am J Clin Nutr. 2006;83:1505S-19S.
48. Bennett DC,Code WE,Godin DV,Cheng KM.Comparison of the antioxidant properties of emu oil with other avian oils.Aust J Exp Agric. 2008;48:1345-50.
49. Klebanoff SJ.Myeloperoxidase: friend and foe.J Leukoc Biol. 2005;77:598-625.